Brief: Titan Pharmaceuticals Q1 Loss Per Share $0.07
15/05/2020 14:04
May 15 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL
RESULTS
* Q1 LOSS PER SHARE $0.07
* Q1 REVENUE $1.3 MILLION
* AS OF MARCH 31, 2020, TITAN HAD CASH AND CASH EQUIVALENTS
OF
APPROXIMATELY $8.0 MILLION
* TITAN PHARMACEUTICALS - BELIEVES, CASH & CASH EQUIVALENTS
TOGETHER WITH PROCEEDS FROM PPP LOAN SUFFICIENT TO FUND PLANNED
OPERATIONS THROUGH Q3 2020
Source text for Eikon: ID:nPnbqkHXKa
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.